One of the limitations facing the development of Streptococcus gordonii into a successful vaccine vector is the inability of this bacterium to express high levels of heterologous proteins. In the present study, we have identified 12 codons deemed as rare codons in S. gordonii and seven other streptococcal species. tRNA genes encoding 10 of the 12 rare codons were cloned into a plasmid. The plasmid was transformed into strains of S. gordonii expressing the fusion protein SpaP/S1, the anti-complement receptor 1 (CR1) single-chain variable fragment (scFv) antibody, or the Toxoplasma gondii cyclophilin C18 protein. These three heterologous proteins contained high percentages of amino acids encoded by rare codons. The results showed that the production of SpaP/S1, anti-CR1 scFv and C18 increased by 2.7-, 120-and 10-fold, respectively, over the control strains. In contrast, the production of the streptococcal SpaP protein without the pertussis toxin S1 fragment was not affected by tRNA gene supplementation, indicating that the increased production of SpaP/S1 protein was due to the ability to overcome the limitation caused by rare codons required for the S1 fragment. The increase in anti-CR1 scFv production was also observed in Streptococcus mutans following tRNA gene supplementation. Collectively, the findings in the present study demonstrate for the first time, to the best of our knowledge, that codon-usage bias exists in Streptococcus spp. and the limitation of heterologous protein expression caused by codon-usage bias can be overcome by tRNA supplementation.
INTRODUCTION
Streptococcus gordonii, a commensal bacterium of the human oral cavity, has gained interest as a live oral vaccine vehicle (Lee, 2003; Medaglini et al., 1997) . One of the major limitations facing the development of Streptococcus gordonii into a successful live vaccine vector is the inability of this bacterium to express high levels of heterologous proteins. It is believed that a number of 'bottlenecks' exist that limit heterologous protein expression, including codon-usage bias, inefficient translocation and folding of proteins, and degradation by cell-wallassociated and extracellular proteases (Tjalsma et al., 2004) .
Codon-usage bias is one of the best understood and characterized bottlenecks (Gustafsson et al., 2004) . Bacteria have biases towards certain codons, using some more frequently than others. As a result, some tRNAs exist in very low quantities because the associated codons are rarely used. When heterologous genes containing a high percentage of rare codons are being expressed, protein translation is stalled or terminated due to the lack of charged tRNAs, resulting in truncated proteins and in lower levels of heterologous protein expression (Baca & Hol, 2000; Kane, 1995) . One way to circumvent codon-usage bias is to supplement the bacterium with tRNAs for the rare codons on plasmids (Brinkmann et al., 1989; Hua et al., 1994) . This method has proved to be successful in Escherichia coli, as demonstrated by commercially available plasmids carrying tRNA genes for rare codons (e.g. pRARE2). There are many examples in the literature demonstrating the increased yield of foreign proteins in E. coli using this approach (Baca & Hol, 2000; Kim & Lee, 2006; Zdanovsky & Zdanovkaia, 2000) . Alternatively, expression of heterologous genes can be optimized by converting rare codons into more frequently used codons (Sorensen et al., 2003) . This conversion has significantly increased yields of human interleukin-18 (hIL-18) and a malaria candidate vaccine when expressed in E. coli (Li et al., 2003; Zhou et al., 2004) .
To our knowledge, the problem of codon-usage bias and the means to overcome it have not been reported for the genus Streptococcus. In the present study, we have identified 12 codons that are deemed to be rare in Streptococcus and demonstrated that the difficulty in expressing a number of heterologous proteins can be overcome by tRNA supplementation. This finding could have far-reaching implications in gene expression in the genus Streptococcus as many species are important in industry and medicine.
METHODS
Bacteria and growth conditions. Streptococcus gordonii RJM4 was constructed previously (Lee et al., 1999) . It carries the spaP/s1 fusion gene on its chromosome. spaP encodes the major surface LPXTG protein SpaP (also named P1 or antigen I/II) from Streptococcus mutans (Lee et al., 1989) . s1 encodes the N-terminal 179 aa fragment of pertussis toxin subunit S1 and is fused to the middle part of spaP (Lee et al., 1999) . S. gordonii SMI/II-4 carries spaP on its chromosome. This strain was constructed by transforming the suicide plasmid pSMI/II-4 into S. gordonii (hppG : : tet; Lee et al., 2002) . pSMI/II-4 was derived from pSMI/II-3 (Homonylo-McGavin & Lee, 1996) by deleting the 4.5 kb DNA fragment carrying the streptococcal origin of replication, but the plasmid still carries spaP. Thus, S. gordonii RJM4 and SMI/II-4 are similar in that they carry one copy of spaP/s1 and spaP on the chromosome, respectively. S. gordonii SecCR1 was constructed previously (Knight et al., 2008) . It carries the synthetic single-chain variable fragment (scFv) antibody against the complement receptor 1 (CR1) on the E. coli-Streptococcus shuttle vector pDL276. S. gordonii SecC18 was constructed in this study. DNA encoding Toxoplasma gondii cyclophilin 18 (C-18) protein was amplified by PCR from pKJ97 (High et al., 1994) using the primer pair SL330 (59-CCTGGCCCAGGCGGCCGAAAATG-CCGGAGTCAGAAAG-39 and SL331 (59-CCTGGCCGGCCTGGCC-CTCCAACAAACCAATGTCCGT-39) (SfiI sites underlined). The 514 bp PCR fragment encoding mature C-18 was inserted into the SfiI sites on pSecCR1 (Knight et al., 2008) , giving pSecC18. The plasmid was then transformed into S. gordonii (hppG : : tet), yielding S. gordonii SecC18. S. mutans SecCR1 was obtained by transforming pSecCR1 into S. mutans 834 (spaP : : tet; Lee et al., 1989) .
S. gordonii and S. mutans were grown in TYG (1 % tryptone, 0.5 % yeast extract, 0.3 % K 2 HPO 4 and 0.2 % glucose; all w/v) in a 5 % CO 2 incubator at 37 uC. Kanamycin, spectinomycin and tetracycline were included in the medium when needed at 250, 250 and 10 mg ml 21 , respectively. Recombinant E. coli was grown aerobically with vigorous shaking at 37 uC in Luria-Bertani broth (1 % tryptone, 0.5 % yeast extract and 1 % NaCl; all w/v) containing (mg ml
21
) of ampicillin (100), kanamycin (50) or spectinomycin (50).
Construction of ptRNA2. Fig. 1 depicts the steps in the construction of ptRNA2. The tRNA genes for AGG (argW), CGG (argX), CGA (argN5), AUA (ileX), CUA (leuW) and CCC (proL) were amplified by PCR as a 2968 bp DNA fragment from pRARE2 (Novagen) using the primers SL433/SL434 (Table 1 ). The PCR fragment also contained six other tRNA genes (argU, metT, thrT, thrU, glyT and glyT), which are not deemed to be rare-codon tRNA genes for Streptococcus. The PCR product was restricted with SstI and SmaI, and cloned into the same sites on the E. coli-Streptoccocus shuttle vector pDL278 (LeBlanc et al., 1992) , creating pRARE2/278. The tRNA genes for CCG (proK), UCC (serW), UCG (serU) and CUG (leuT) were amplified by PCR from the chromosome of E. coli XL-1 Blue using primer pairs listed in Table 1 . The PCR products for proK, serW and serU were restricted by EcoRI and HindIII, and ligated by T4 DNA ligase. The ligated DNA was amplified by PCR using primers SL455/SL460, restricted with SalI and BamHI, and cloned into the same sites on pUC19, creating ptRNA-KWU. The leuT tRNA gene fragment also carried the structural gene (but not the promoter) for the hisR tRNA gene, and was first cloned into the HindIII and BamHI sites on pBluescript, then excised from the plasmid as a KpnI-BamHI fragment and cloned into ptRNA-KWU. The SalI-ScaI fragment carrying these four tRNA genes was then cloned into the SalI-SmaI sites on pRARE2/278. The resulting plasmid was named ptRNA2, carrying the tRNA genes for 10 rare codons and 7 other tRNA genes on the E. coli-Streptococcus shuttle plasmid pDL278. The plasmid was maintained in E. coli XL-1 Blue.
RNA isolation and reverse transcription-PCR (RT-PCR). RNA was extracted using the method as described by Peterson et al. (2000) with modifications. S. gordonii SecCR1 carrying ptRNA2 or pDL278 was grown to mid-exponential phase (OD 600 #0.6) and cells were collected by centrifugation (14 000 g, 10 min). The cells (3.0610 10 c.f.u.) were resuspended in 500 ml diethyl pyrocarbonate (DEPC)-treated water. Five millilitres of phenol, which contained 0.1 % (w/v) SDS and saturated with citric acid buffer (50 mM sodium citrate, 50 mM citric acid, pH 4.3 with citric acid), was added. The suspension was boiled for 10 min and then cooled on ice. The aqueous phase was separated by centrifugation (3000 g, 10 min), extracted once with 2 vols acidic phenol/chloroform (1 : 1; 3000 g, 7.5 min), and then with 2 vols chloroform (3000 g, 7.5 min). The RNA was precipitated with 2 vols isopropyl alcohol in the presence of 0.3 M sodium acetate. The precipitated RNA was collected by centrifugation (15 000 g, 20 min), washed with 75 % ethanol, and dissolved in 50 ml DEPC-treated water. The RNA was then treated with 100 U RNase-free DNase I (SigmaAldrich) for 15 min at room temperature, extracted with acidic phenol/ chloroform followed by chloroform and precipitated. The RNA was dissolved in DEPC-treated water.
Reverse transcription reactions were performed for 50 min at 42 uC, using 200 ng RNA, 200 ng random primers (Invitrogen) and 200 U SuperScript II reverse transcriptase (Invitrogen) in a total volume of 20 ml 16 First Strand Buffer (Invitrogen) containing 10 mM dithiothreitol and 0.5 mM each dNTP. Mock transcription was carried out in parallel as a control using the same amount of RNA, but the reverse transcriptase was omitted. Following the reaction, the mixtures were heated for 15 min at 70 uC, cooled and treated with 20 U DNase-free RNase A (Sigma-Aldrich) and 2 U RNase H (Invitrogen) for 30 min at 37 uC.
PCR was carried out using 1 ml cDNA or materials from mock transcription, 20 pmol tRNA primers (Table 1 ) and 0.5 U Taq DNA polymerase in 50 ml reaction volumes containing 1.5 mM MgCl 2 and 0.2 mM each dNTP. PCR was performed under the following cycling parameters: 95 uC for 3 min, followed by 30 cycles of 95 uC for 1 min, 65 uC for 30 s and 72 uC for 15 s, followed by 72 uC for 5 min. The PCR products were analysed on a 2 % agarose gel by electrophoresis.
SDS-PAGE and Western blotting. Following growth, bacterial cultures were standardized to an OD 600 of 1 and incubated with 5 % (w/v) TCA on ice for 30 min. Samples were then centrifuged for 5 min at 10 000 g. Supernatants were discarded and the pellet was washed once with 1 ml cold acetone and air-dried. The pellets were resuspended in the sample buffer of Laemmli (1970) , boiled for 5 min, and centrifuged. Proteins in the supernatants were analysed by SDS-PAGE on polyacrylamide gels using the buffer system of Laemmli (1970) . Proteins were stained with Coomassie Blue R-250. For Western immunoblotting, proteins were transferred to nitrocellulose membranes (Towbin et al., 1979) . The SpaPS1 protein was detected by the anti-S1 monoclonal antibody A4 (1/4000; Halperin et al., 1991) . The SpaP protein was detected by the monoclonal antibody 4-10A (1/7000; Ayakawa et al., 1987) . The anti-CR1 scFv and C18 proteins were detected using the anti-HA tag monoclonal antibody (1/10 000; Sigma Aldrich). The secondary antibody used was a goat anti-mouse IgG Microbiology 155 Downloaded from www.microbiologyresearch.org by IP: 54.70.40.11
On: Sun, 03 Feb 2019 22:58:37 alkaline phosphatase conjugated antibody (1/20 000; Sigma-Aldrich). The intensity of the full-length 195 kDa SpaP/S1, 185 kDa SpaP, 31 kDa anti-CR1 scFv and 21 kDa C18 immunoreactive bands was estimated from three independent experiments by using Image J software (National Institutes of Health, Bethesda, MD, USA).
Statistical analysis. The results were analysed by Student's t-test for two-sample equal variant populations with two-tailed distribution, and a P-value of ,0.05 was considered significant.
RESULTS

Identification of rare codons in Streptococcus
Examination of codon usage in S. gordonii revealed that 12 codons occurred at a low frequency (¡15 per thousand) (Table 2 ). These 12 codons were also used at low frequencies in seven other Streptococcus species with two exceptions: CUG and CCG in S. sanguinis, and AUA in S. agalactiae were used at high frequency. In E. coli, 9 of the 12 codons showed a similar low usage, but GCG, CUG and CCG were used at high frequency.
Construction of a rare-codon tRNA plasmid
To facilitate the attempt to overcome the limitation imposed by codon-usage bias when expressing heterologous proteins in Streptococcus, a plasmid carrying 17 tRNA genes was constructed on the E. coli-Streptococcus shuttle plasmid pDL278. Fig. 1 depicts the construction of this plasmid, named ptRNA2. The plasmid carries the tRNA genes for 10 Fig. 1 . Construction of ptRNA2. The solid bar on pRARE2/278 indicates the 2968 bp DNA fragment carrying six rare tRNA genes (argW, argX, argN5, ileX, leuW and proL) in addition to six other tRNA genes (argU, metT, thrT, thrU, glyT and glyT). See Methods for details. pBS, pBluescript. rare codons (CGG, CGA, AGG, AUA, CUG, CUA, CCG, CCC, UCC and UCG), and 7 other tRNA genes that are not deemed to be rare tRNAs for Streptococcus.
Overcoming rare-codon-usage bias in S. gordonii
To test the ability of ptRNA2 to overcome the limitation of codon-usage bias in the expression of heterologous proteins in Streptoccocus, the plasmid was transformed into S. gordonii RJM4, which carries a genetic fusion of the N-terminal 179-aa fragment of S1 subunit of pertussis toxin and the surface protein SpaP from S. mutans (Lee et al., 1999) . The level of expression of the SpaP/S1 fusion has been reported previously to be low (Lee et al., 1999; Mallaley et al., 2006) . The S1 sequence contains 15.6 % (28 of 179 amino acids) rare codons, while the SpaP sequence has 3.7 % (58 of 1573 amino acids) rare codons (Table 3) . ptRNA2 was also transformed into S. gordonii SMI/II-4, which carries only spaP without s1. The transformants were analysed for the expression of spaP/s1 or spaP by Western blotting. As shown in Fig. 2 , the expression of SpaP1/S1 increased by 2.7±0.3-fold (mean±SD, P,0.005) in S. gordonii RJM4 carrying ptRNA2 compared to S. gordonii RJM4 carrying the control plasmid pDL278 (a, b). In contrast, the level of SpaP expression by S. gordonii SMI/II-4 was not affected by ptRNA2 (Fig. 2c, d , P.0.1).
To further demonstrate the ability of ptRNA2 to overcome rare-codon-usage bias, the expression of two other heterologous proteins in S. gordonii was tested. The first heterologous protein was an scFv antibody against CR1 (Knight et al., 2008) , and the second was cyclophilin C18 from T. gondii (High et al., 1994) . The anti-CR1 scFv and C18 sequences contain 14.0 % (41 of 293 amino acids) and 8.1 % (13 of 162 amino acids) rare codons, respectively (Table 3) . S. gordonii SecCR1 carrying pDL278 produced a minute amount of anti-CR1 scFv (Fig. 3) . Convincingly, when S. gordonii SecCR1was transformed with ptRNA2, the yield of anti-CR1 scFv was increased by 120±10-fold (mean±SD, P,0.001). Similarly, ptRNA2 was able to increase the production of C18 by 10±1-fold (mean±SD, P,0.01) by S. gordonii SecC18. 
To provide further support for the result described above, the expression of the 10 rare-codon tRNA genes was examined by RT-PCR. As shown in Fig. 4 , the fact that these 10 tRNAs were detected following reverse transcription strongly indicates that the genes were expressed in S. gordonii.
Overcoming codon-usage bias in S. mutans
To demonstrate that the effect of ptRNA2 was not limited to S. gordonii, ptRNA2 was transformed into S. mutans SecCR1. As shown in Fig. 5 , S. mutans SecCR1 carrying ptRNA2 produced 4.8±0.5-fold (mean±SD, P,0.05) more anti-CR1 scFv than S. mutans SecCR1 carrying the control plasmid pDL278.
DISCUSSION
In the present study, we have identified 12 codons that are used at low frequency in S. gordonii. In general, these 12 codons are also used at low frequency in seven other Streptococcus species, suggesting that this is a common feature among species of this genus. Nine of the 12 codons are also used at low frequency in E. coli, but the remaining three codons are not, highlighting the differences between Streptococcus and E. coli.
We were able to clone or subclone 10 rare-codon tRNA genes from E. coli and the commercial plasmid pRARE2. Transformation of the plasmid carrying the 10 tRNA genes into S. gordonii resulted in an increased production of three heterologous proteins, whose genes were from three different phylogenetic origins. The S1 fragment was from a Gram-negative bacterium, Bordetella pertussis, C18 was from a parasite, T. gondii, and anti-CR1 scFv was from a murine source. In addition, ptRNA2 also increased the production of anti-CR1 scFv in S. mutans. These results clearly indicate the utility of ptRNA2. 
